Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812188 · ClinicalTrials.gov registry record · NA
Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00812188 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT00812188, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.
Interventions
- OTHER Medium Dose UVA-1
- OTHER High Dose UVA-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-11 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812188
The ClinicalTrials.gov registry entry for NCT00812188 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medium Dose UVA-1 is the first listed.
NCT00812188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812188 about?
NCT00812188 is a clinical study titled "Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.". Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.
What is the current status of trial NCT00812188?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2004-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00812188?
The interventions under investigation include: Medium Dose UVA-1 (OTHER), High Dose UVA-1 (OTHER).
Who is sponsoring clinical trial NCT00812188?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.